BROOKSBSEBrooks Laboratories LtdMediumNeutral
Announced Fri, 29 May · 20:21 IST

Appointment of Chief Executive Officer.

Management Changes View source PDF

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹65.29
prior close
₹68.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.5-0.0+0.0+3.2-0.4+0.9+0.8+2.6+4.5+7.2+10.7
Up moveDown movePending
AI summary

Brooks Laboratories Ltd has appointed Mr. Prashant Rathi as Chief Executive Officer effective 1st June 2026. Importantly, Rathi will continue serving as Chief Financial Officer (CFO) in addition to the new CEO role. He is a Chartered Accountant, Company Secretary, and holds a Diploma in IFRS from ACCA, UK, bringing over 13 years of experience in accounting and finance. Rathi has been with the company for over five years and has deep familiarity with its operations and financial systems.

Likely market impact

The dual role consolidation of CEO and CFO in one person may raise questions about governance and workload distribution. No immediate shareholder impact is expected, but market participants may monitor whether this structure is temporary or permanent.